C
Novo Nordisk A/S NVO
$65.77 $0.921.42% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue 43.59B 42.09B 39.35B 37.42B 35.53B
Total Other Revenue -- -- -- -- --
Total Revenue 43.59B 42.09B 39.35B 37.42B 35.53B
Cost of Revenue 6.69B 6.32B 5.97B 5.73B 5.39B
Gross Profit 36.90B 35.77B 33.38B 31.69B 30.14B
SG&A Expenses 9.94B 9.76B 9.55B 9.16B 9.09B
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -151.29M -66.61M -5.46M -34.65M 25.98M
Total Operating Expenses 22.48B 21.82B 21.00B 20.12B 19.31B
Operating Income 21.11B 20.27B 18.36B 17.30B 16.23B
Income Before Tax 19.03B 18.45B 17.36B 16.39B 16.28B
Income Tax Expenses 3.98B 3.80B 3.57B 3.34B 3.29B
Earnings from Continuing Operations 15.05K 14.65K 13.79K 13.05K 12.99K
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 15.05B 14.65B 13.79B 13.05B 12.99B
EBIT 21.11B 20.27B 18.36B 17.30B 16.23B
EBITDA 22.66B 21.60B 19.65B 18.65B 17.44B
EPS Basic 3.38 3.29 3.09 2.92 2.91
Normalized Basic EPS 2.91 2.82 2.59 2.45 2.32
EPS Diluted 3.38 3.28 3.09 2.91 2.90
Normalized Diluted EPS 2.90 2.82 2.58 2.45 2.31
Average Basic Shares Outstanding 17.80B 17.82B 17.83B 17.86B 17.89B
Average Diluted Shares Outstanding 17.83B 17.85B 17.87B 17.90B 17.94B
Dividend Per Share 1.63 1.63 1.43 1.43 1.36
Payout Ratio 48.33% 44.06% 46.82% 46.91% 47.10%